All News

Phase 3 trials show once-daily bictegravir/lenacapavir keeps HIV suppressed after switching regimens, with strong safety and better satisfaction for complex-treatment patients.

Orforglipron beats oral semaglutide in A1C and weight loss in a head-to-head study for type 2 diabetes.

Long-term care pharmacists shift to safety-first care by deprescribing anticholinergics, using dysphagia-friendly forms, and raising vaccination rates.

Navitus Health Solutions conducted a survey of 2000 US adults who have been taking glucagon-like peptide-1 therapies for the past 2 years.

In part 2 of our conversation with CLIAwaived Inc CEO Tim Drapeau, we explored the future horizons in community pharmacy and how at-home testing is advancing the pharmacist’s role in health care.

Three-year QUASAR data show guselkumab keeps most ulcerative colitis patients in remission, with strong healing rates and no new safety issues.

Upon approval, dupilumab becomes the first and only medication on the market to target adult and pediatric patients’ allergic fungal rhinosinusitis.

Novo Nordisk’s CagriSema drives 23% weight loss in REDEFINE 4 but misses noninferiority compared with tirzepatide, shaping the next wave of obesity drugs.

In a post-hoc analysis, researchers testnm the effects of tezepelumab against placebo among patients with severe uncontrolled asthma.

The FDA approves Bysanti (milsaperidone) for schizophrenia and bipolar I disorder, leveraging iloperidone bioequivalence, with key metabolic monitoring needs.

New data links glucagon-like peptide-1s to fewer aneurysm ruptures and lower death risk, guiding pharmacists on safer stroke prevention.

Pharmacists help explain the complex evidence, address fears around injections and cost, and help patients integrate lifestyle changes alongside pharmacologic therapy for diabetes care.

Just before monumental PBM reform was signed into law, as well as a landmark settlement between the FTC and Express Scripts, the Department of Labor proposed its own set of PBM regulations.

Using the PRIME program’s framework, researchers explore a digital-health and pharmacy-based lifestyle intervention for improving risk factors among patients with prediabetes.

Community pharmacists strengthen disaster response by coordinating vaccines, bridging care gaps, and securing lifesaving meds under pressure.

Pharmacists help turn Food Is Medicine into covered care, linking heart patients to tailored meals, produce prescriptions, and easier chronic disease prevention.

In a reversal of its refusal-to-file letter issued last week, the FDA decides to move forward with Moderna’s mRNA flu vaccine developments.

Amid common patient threats stemming from severe hypoglycemia, researchers explore how proactive pharmacist outreach can translate to safer prescribing regimens for patients with diabetes.

Jeff Goad, PharmD, MPH, joins Drug Topics to discuss potential COVID-19 vaccine removal and what it could mean for the future of mRNA vaccine technology.

Duvakitug TL1A antibody sustains remission and endoscopic response for 44 weeks in ulcerative colitis and Crohn disease, supporting phase 3 momentum.

The FDA approves pitolisant for pediatric cataplexy, offering a rare noncontrolled narcolepsy option with real-world safety data and key interaction tips.

Positive phase 3 data from its KALOS and LOGOS trials show the efficacy and safety of Breztri compared with 2 additional therapies.

Through a mathematical model used to assess asthma dynamics, researchers explore how active smoking can impact disease outcomes.

With expanding scopes of practice, there has never been a better time to introduce or expand clinical services that improve patient outcomes.

Tennessee’s 2024 expansion of pharmacist's scope of practice authorizes independent prescribing and test-and-treat services, positioning pharmacists as primary care extenders in underserved communities.

Understanding acceptable thresholds helps prevent unnecessary discontinuation of guideline-directed therapy.

In a move that comes as a surprise to Moderna and various vaccine experts, the FDA continues its skeptic exploration of mRNA vaccine technology.

Amid evolving standards of care in the management of diabetes, researchers explore the role of pharmacists in facilitating continuous glucose monitoring education.